Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA · Financial Services · $361M
After-hours $10.72+0.09%
Price
$10.60
$10.71
May 7, 26Aug 6, 26
Quarterly Financials
RevenueOperating IncomeNet Income
3/'26
Revenue$0M
Operating Income-$0M+93.1%
Net Income$2M+825.3%
12/'25 vs prev quarter
Company Health
Cash on Hand$14,887
PER54.3x
PBR1.5x
ROE+2.8%
